{"id":"https://openalex.org/W2005333158","doi":"https://doi.org/10.1007/s40273-013-0048-3","title":"Lopinavir/Ritonavir Versus Darunavir Plus Ritonavir for HIV Infection: A Cost-Effectiveness Analysis for the United States","display_name":"Lopinavir/Ritonavir Versus Darunavir Plus Ritonavir for HIV Infection: A Cost-Effectiveness Analysis for the United States","publication_year":2013,"publication_date":"2013-04-26","ids":{"openalex":"https://openalex.org/W2005333158","doi":"https://doi.org/10.1007/s40273-013-0048-3","mag":"2005333158","pmid":"https://pubmed.ncbi.nlm.nih.gov/23620210"},"language":"en","primary_location":{"id":"doi:10.1007/s40273-013-0048-3","doi":"https://doi.org/10.1007/s40273-013-0048-3","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s40273-013-0048-3","pdf_url":null,"source":{"id":"https://openalex.org/S43019230","display_name":"PharmacoEconomics","issn_l":"1170-7690","issn":["1170-7690","1179-2027"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043515095","display_name":"Kit N. Simpson","orcid":"https://orcid.org/0000-0002-1713-0632","observed_orcids":["https://orcid.org/0000-0002-1713-0632"]},"institutions":[{"id":"https://openalex.org/I153297377","display_name":"Medical University of South Carolina","ror":"https://ror.org/012jban78","country_code":"US","type":"education","lineage":["https://openalex.org/I153297377"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Kit N. Simpson","raw_affiliation_strings":["Department of Health Leadership and Management, College of Health Professions, Medical University of South Carolina, 151B Rutledge Ave., Room 412, Charleston, SC 29425, USA. simpsonk@musc.edu","Department of Health Leadership and Management, College of Health Professions, Medical University of South Carolina, 151B Rutledge Ave., Room 412, Charleston, SC, 29425, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Health Leadership and Management, College of Health Professions, Medical University of South Carolina, 151B Rutledge Ave., Room 412, Charleston, SC 29425, USA. simpsonk@musc.edu","institution_ids":["https://openalex.org/I153297377"]},{"raw_affiliation_string":"Department of Health Leadership and Management, College of Health Professions, Medical University of South Carolina, 151B Rutledge Ave., Room 412, Charleston, SC, 29425, USA","institution_ids":["https://openalex.org/I153297377"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061118173","display_name":"Pamela P. Pei","orcid":"https://orcid.org/0000-0002-6095-8494","observed_orcids":["https://orcid.org/0000-0002-6095-8494"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pamela P. Pei","raw_affiliation_strings":["Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA","United BioSource Corporation, Lexington, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I4210087915"]},{"raw_affiliation_string":"United BioSource Corporation, Lexington, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010487091","display_name":"J\u00f6rgen M\u00f6ller","orcid":"https://orcid.org/0000-0002-8194-864X","observed_orcids":["https://orcid.org/0000-0002-8194-864X"]},"institutions":[{"id":"https://openalex.org/I4210087505","display_name":"United BioSource Corporation (United Kingdom)","ror":"https://ror.org/003m2d425","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210087505"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J\u00f6rgen M\u00f6ller","raw_affiliation_strings":["United BioSource Corporation, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"United BioSource Corporation, London, UK","institution_ids":["https://openalex.org/I4210087505"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109964613","display_name":"Robert W. Baran","orcid":"https://orcid.org/0009-0008-8852-6993","observed_orcids":["https://orcid.org/0009-0008-8852-6993"]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert W. Baran","raw_affiliation_strings":["Abbott Laboratories, Abbott Park, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abbott Laboratories, Abbott Park, IL, USA","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113715360","display_name":"Birgitta Dietz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126753","display_name":"Abbott (Germany)","ror":"https://ror.org/02x2gk324","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210088555","https://openalex.org/I4210126753"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Birgitta Dietz","raw_affiliation_strings":["Abbott GmbH & Co. KG, Ludwigshafen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abbott GmbH & Co. KG, Ludwigshafen, Germany","institution_ids":["https://openalex.org/I4210126753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111759491","display_name":"William C. Woodward","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088555","display_name":"Abbott (United States)","ror":"https://ror.org/0052svj16","country_code":"US","type":"company","lineage":["https://openalex.org/I4210088555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William Woodward","raw_affiliation_strings":["Abbott Laboratories, Abbott Park, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abbott Laboratories, Abbott Park, IL, USA","institution_ids":["https://openalex.org/I4210088555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058536300","display_name":"Kristen Migliaccio\u2013Walle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210102964","display_name":"Institute for Clinical and Economic Review","ror":"https://ror.org/011ypgb65","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210102964"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristen Migliaccio-Walle","raw_affiliation_strings":["Institute for Clinical and Economic Review, Massachusetts General Hospital, Boston, MA, USA","United BioSource Corporation, Lexington, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Clinical and Economic Review, Massachusetts General Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I4210087915","https://openalex.org/I4210102964"]},{"raw_affiliation_string":"United BioSource Corporation, Lexington, MA, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5016786296","display_name":"J. Jaime","orcid":"https://orcid.org/0000-0001-5470-3754","observed_orcids":["https://orcid.org/0000-0001-5470-3754"]},"institutions":[{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"J. Jaime Caro","raw_affiliation_strings":["Faculty of Medicine, McGill University, Montreal, QC, Canada","United BioSource Corporation, Lexington, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Medicine, McGill University, Montreal, QC, Canada","institution_ids":["https://openalex.org/I5023651"]},{"raw_affiliation_string":"United BioSource Corporation, Lexington, MA, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5043515095"],"corresponding_institution_ids":["https://openalex.org/I153297377"],"apc_list":{"value":4990,"currency":"USD","value_usd":4990},"apc_paid":null,"fwci":2.4238,"has_fulltext":false,"cited_by_count":23,"citation_normalized_percentile":{"value":0.88063924,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"31","issue":"5","first_page":"427","last_page":"444"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.7993000149726868,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.7993000149726868,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.13279999792575836,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.04809999838471413,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lopinavir-ritonavir","display_name":"lopinavir/ritonavir","score":0.9570000171661377},{"id":"https://openalex.org/keywords/darunavir-ritonavir","display_name":"darunavir/ritonavir","score":0.9279999732971191},{"id":"https://openalex.org/keywords/hiv-1-infection","display_name":"HIV-1 infection","score":0.9290000200271606},{"id":"https://openalex.org/keywords/first-line-antiretroviral-therapy","display_name":"first-line antiretroviral therapy","score":0.9440000057220459},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.968999981880188},{"id":"https://openalex.org/keywords/artemis-trial","display_name":"ARTEMIS trial","score":0.8759999871253967},{"id":"https://openalex.org/keywords/discrete-event-simulation","display_name":"discrete event simulation","score":0.7710000276565552},{"id":"https://openalex.org/keywords/emtricitabine-tenofovir","display_name":"tenofovir/emtricitabine","score":0.8759999871253967},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.753000020980835},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.7139999866485596},{"id":"https://openalex.org/keywords/treatment-switching","display_name":"treatment switching","score":0.4169999957084656},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.5099999904632568},{"id":"https://openalex.org/keywords/virological-rebound","display_name":"virologic rebound","score":0.6169999837875366},{"id":"https://openalex.org/keywords/cardiovascular-events","display_name":"cardiovascular events","score":0.375}],"concepts":[{"id":"https://openalex.org/C2779182219","wikidata":"https://www.wikidata.org/wiki/Q3765251","display_name":"Darunavir","level":5,"score":0.9201015830039978},{"id":"https://openalex.org/C2777182164","wikidata":"https://www.wikidata.org/wiki/Q422585","display_name":"Lopinavir","level":5,"score":0.864108145236969},{"id":"https://openalex.org/C2779778239","wikidata":"https://www.wikidata.org/wiki/Q422604","display_name":"Emtricitabine","level":5,"score":0.8246872425079346},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7266407012939453},{"id":"https://openalex.org/C2779298103","wikidata":"https://www.wikidata.org/wiki/Q422618","display_name":"Ritonavir","level":5,"score":0.7105539441108704},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5974752902984619},{"id":"https://openalex.org/C2781392899","wikidata":"https://www.wikidata.org/wiki/Q422618","display_name":"Lopinavir/ritonavir","level":5,"score":0.5338735580444336},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.48867300152778625},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4348200857639313},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.42621922492980957},{"id":"https://openalex.org/C515549039","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost-effectiveness analysis","level":3,"score":0.4104398488998413},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3921588361263275},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37380439043045044},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.28917524218559265},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.22089016437530518},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.19167467951774597},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.08351391553878784}],"mesh":[{"descriptor_ui":"D000069454","descriptor_name":"Darunavir","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017048","descriptor_name":"Health Care Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018803","descriptor_name":"Models, Economic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019057","descriptor_name":"Quality-Adjusted Life Years","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019438","descriptor_name":"Ritonavir","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019438","descriptor_name":"Ritonavir","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D019438","descriptor_name":"Ritonavir","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D061466","descriptor_name":"Lopinavir","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D061466","descriptor_name":"Lopinavir","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D061466","descriptor_name":"Lopinavir","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1007/s40273-013-0048-3","doi":"https://doi.org/10.1007/s40273-013-0048-3","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s40273-013-0048-3","pdf_url":null,"source":{"id":"https://openalex.org/S43019230","display_name":"PharmacoEconomics","issn_l":"1170-7690","issn":["1170-7690","1179-2027"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics","raw_type":"journal-article"},{"id":"pmid:23620210","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23620210","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PharmacoEconomics","raw_type":"Comparative Study"},{"id":"pmh:oai:RePEc:spr:pharme:v:31:y:2013:i:5:p:427-444","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/10.1007/s40273-013-0048-3","pdf_url":null,"source":{"id":"https://openalex.org/S4306401271","display_name":"RePEc: Research Papers in Economics","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I77793887","host_organization_name":"Federal Reserve Bank of St. Louis","host_organization_lineage":["https://openalex.org/I77793887"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":70,"referenced_works":["https://openalex.org/W49125497","https://openalex.org/W1965317332","https://openalex.org/W1966068165","https://openalex.org/W1971383126","https://openalex.org/W1972524622","https://openalex.org/W1978517544","https://openalex.org/W1980238549","https://openalex.org/W1982988962","https://openalex.org/W1985662879","https://openalex.org/W1994222210","https://openalex.org/W1995346719","https://openalex.org/W1998532326","https://openalex.org/W1999040828","https://openalex.org/W2002660064","https://openalex.org/W2003479257","https://openalex.org/W2004681966","https://openalex.org/W2005258693","https://openalex.org/W2013329800","https://openalex.org/W2019069506","https://openalex.org/W2024888854","https://openalex.org/W2026063780","https://openalex.org/W2026641194","https://openalex.org/W2030868194","https://openalex.org/W2031968478","https://openalex.org/W2037809152","https://openalex.org/W2038002163","https://openalex.org/W2042504406","https://openalex.org/W2045131275","https://openalex.org/W2046169609","https://openalex.org/W2059126135","https://openalex.org/W2075052091","https://openalex.org/W2076339980","https://openalex.org/W2082196563","https://openalex.org/W2085088518","https://openalex.org/W2087036576","https://openalex.org/W2090669065","https://openalex.org/W2094744919","https://openalex.org/W2101147834","https://openalex.org/W2103513664","https://openalex.org/W2106512674","https://openalex.org/W2107405926","https://openalex.org/W2116258000","https://openalex.org/W2117419474","https://openalex.org/W2118715260","https://openalex.org/W2121179908","https://openalex.org/W2124543441","https://openalex.org/W2133649749","https://openalex.org/W2134023402","https://openalex.org/W2134240104","https://openalex.org/W2135417699","https://openalex.org/W2136683144","https://openalex.org/W2137262613","https://openalex.org/W2140747910","https://openalex.org/W2144984387","https://openalex.org/W2155331329","https://openalex.org/W2160970334","https://openalex.org/W2164099498","https://openalex.org/W2166545019","https://openalex.org/W2166670196","https://openalex.org/W2170073443","https://openalex.org/W2170239385","https://openalex.org/W2171310617","https://openalex.org/W2183940924","https://openalex.org/W2318289184","https://openalex.org/W2320369730","https://openalex.org/W2339219218","https://openalex.org/W2793717112","https://openalex.org/W3143265745","https://openalex.org/W4247917425","https://openalex.org/W4296391115"],"related_works":["https://openalex.org/W1983896142","https://openalex.org/W2124777219","https://openalex.org/W2167922785","https://openalex.org/W2032425619","https://openalex.org/W2038002163","https://openalex.org/W2167528679","https://openalex.org/W2170073443","https://openalex.org/W2066662272","https://openalex.org/W2114501704","https://openalex.org/W2062568251"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":4},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":5}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}